Microbot Medical (NASDAQ:MBOT – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter.
Microbot Medical Stock Performance
Shares of NASDAQ MBOT opened at $1.70 on Monday. Microbot Medical has a 1 year low of $0.82 and a 1 year high of $3.38. The company has a market capitalization of $59.06 million, a PE ratio of -2.12 and a beta of 1.60. The company’s fifty day moving average price is $1.76 and its 200 day moving average price is $1.30.
Analysts Set New Price Targets
Separately, HC Wainwright increased their price target on Microbot Medical from $7.00 to $9.00 and gave the stock a “buy” rating in a research report on Friday, January 24th.
Microbot Medical Company Profile
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Featured Articles
- Five stocks we like better than Microbot Medical
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- What is a Stock Market Index and How Do You Use Them?
- 3 ETFs to Ride the VIX Surge During Market Volatility
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.
